Antiplatelet Prescription in Atrial Fibrillation: Association with a Low Rate of Anticoagulation
- PMID: 31249946
- PMCID: PMC6524878
- DOI: 10.1055/s-0038-1660506
Antiplatelet Prescription in Atrial Fibrillation: Association with a Low Rate of Anticoagulation
Conflict of interest statement
Dr. Goldhaber has received research grant support from Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, the Thrombosis Research Institute, and Janssen and consulting fees from Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Eisai, and Portola.
Dr. Piazza has received research grant support from Bristol Myers Squibb, Daiichi Sankyo, the Thrombosis Research Institute, and Janssen.
Drs. Karipineni and Goldberg have no relevant financial disclosures.
Figures
References
-
- Hart R G, Pearce L A, Aguilar M I. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146(12):857–867. - PubMed
-
- Ruff C T, Giugliano R P, Braunwald Eet al.Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials Lancet 2014383(9921):955–962. - PubMed
-
- Wann L S, Curtis A B, Ellenbogen K A et al.2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2011;57(11):1330–1337. - PubMed
-
- Connolly S J, Eikelboom J, Joyner C et al.Apixaban in patients with atrial fibrillation. N Engl J Med. 2011;364(09):806–817. - PubMed
-
- Mant J, Hobbs F D, Fletcher Ket al.Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial Lancet 2007370(9586):493–503. - PubMed
LinkOut - more resources
Full Text Sources
